These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 9552578

  • 1. Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study.
    Taylor DJ, Amato A, Hands LJ, Kemp GJ, Ramaswami G, Nicolaides A, Radda GK.
    Vasc Med; 1996; 1(4):241-5. PubMed ID: 9552578
    [Abstract] [Full Text] [Related]

  • 2. 31Phosphorus magnetic resonance spectroscopy to evaluate medical therapy efficacy in peripheral arterial disease. A pilot study.
    Di Marzo L, Miccheli A, Sapienza P, Tedesco M, Mingoli A, Capuani G, Aureli T, Giuliani A, Conti F, Cavallaro A.
    Panminerva Med; 1999 Dec; 41(4):283-90. PubMed ID: 10705707
    [Abstract] [Full Text] [Related]

  • 3. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
    Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD.
    J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo.
    Kemp GJ, Roberts N, Bimson WE, Bakran A, Harris PL, Gilling-Smith GL, Brennan J, Rankin A, Frostick SP.
    J Vasc Surg; 2001 Dec; 34(6):1103-10. PubMed ID: 11743568
    [Abstract] [Full Text] [Related]

  • 5. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.
    Greiner A, Esterhammer R, Messner H, Biebl M, Mühlthaler H, Fraedrich G, Jaschke WR, Schocke MF.
    J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693
    [Abstract] [Full Text] [Related]

  • 6. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
    Thompson CH, Irish AB, Kemp GJ, Taylor DJ, Radda GK.
    Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
    [Abstract] [Full Text] [Related]

  • 7. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy.
    Hands LJ, Bore PJ, Galloway G, Morris PJ, Radda GK.
    Clin Sci (Lond); 1986 Sep; 71(3):283-90. PubMed ID: 3757432
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential of phosphorus nuclear magnetic resonance spectroscopy in studies of the energy metabolism of skeletal muscles.
    Ternovoi SK, Veselova TN, Sinitsin VE.
    Neurosci Behav Physiol; 2003 Sep; 33(7):723-7. PubMed ID: 14552542
    [Abstract] [Full Text] [Related]

  • 13. A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
    Luo T, Li J, Li L, Yang B, Liu C, Zheng Q, Jin B, Chen Z, Li K, Zhang X, Zhang J.
    Thromb Res; 2013 Oct; 132(4):427-32. PubMed ID: 23998557
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D, Bronas UG, Leon AS.
    Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication.
    Frans FA, Zagers MB, Jens S, Bipat S, Reekers JA, Koelemay MJ.
    J Vasc Surg; 2013 Mar; 57(3):720-727.e1. PubMed ID: 23313183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Phosphorus-31 NMR spectrometry of the calf muscles in patients with arterial claudication. Preliminary results].
    Le Bas JF, Reutenauer H, Franco A, Magne JL, Benabid AL.
    J Mal Vasc; 1987 Mar; 12(1):70-7. PubMed ID: 3559414
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.